As of 2025-07-11, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 22.96 USD. This relative valuation is based on P/E multiples. With the latest stock price at 72.01 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -68.1%.
The range of the Relative Valuation is 18.42 - 28.93 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 21.8x | 16.0x |
| Forward P/E multiples | 15.9x - 20.3x | 18.0x |
| Fair Price | 18.42 - 28.93 | 22.96 |
| Upside | -74.4% - -59.8% | -68.1% |
| Date | P/E |
| 2025-07-10 | 56.99 |
| 2025-07-09 | 56.10 |
| 2025-07-08 | 53.94 |
| 2025-07-07 | 53.45 |
| 2025-07-03 | 57.19 |
| 2025-07-02 | 56.46 |
| 2025-07-01 | 54.85 |
| 2025-06-30 | 58.09 |
| 2025-06-27 | 57.94 |
| 2025-06-26 | 58.82 |
| 2025-06-25 | 58.55 |
| 2025-06-24 | 60.75 |
| 2025-06-23 | 58.78 |
| 2025-06-20 | 56.49 |
| 2025-06-18 | 56.38 |
| 2025-06-17 | 56.86 |
| 2025-06-16 | 56.11 |
| 2025-06-13 | 55.44 |
| 2025-06-12 | 56.33 |
| 2025-06-11 | 56.38 |
| 2025-06-10 | 57.19 |
| 2025-06-09 | 55.85 |
| 2025-06-06 | 55.08 |
| 2025-06-05 | 54.61 |
| 2025-06-04 | 55.38 |
| 2025-06-03 | 55.01 |
| 2025-06-02 | 56.73 |
| 2025-05-30 | 61.38 |
| 2025-05-29 | 61.44 |
| 2025-05-28 | 61.45 |
| 2025-05-27 | 60.79 |
| 2025-05-23 | 62.27 |
| 2025-05-22 | 60.22 |
| 2025-05-21 | 59.99 |
| 2025-05-20 | 60.32 |
| 2025-05-19 | 59.21 |
| 2025-05-16 | 59.42 |
| 2025-05-15 | 58.06 |
| 2025-05-14 | 56.06 |
| 2025-05-13 | 55.86 |
| 2025-05-12 | 57.09 |
| 2025-05-09 | 55.58 |
| 2025-05-08 | 56.49 |
| 2025-05-07 | 55.76 |
| 2025-05-06 | 55.98 |
| 2025-05-05 | 58.51 |
| 2025-05-02 | 57.59 |
| 2025-05-01 | 56.57 |
| 2025-04-30 | 56.88 |
| 2025-04-29 | 57.95 |